World first blood cancer drug trial reveals life-changing results
A breakthrough has been achieved with the results of the world-first clinical trial with actual patients of a new drug to treat particular blood cancers. This clinical trial, a first-in-human study, looked at the efficacy of a new inhibitor, ONO/GS-4059, in the treatment of Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma patients refractory or resistant to current chemotherapies.
Source: ScienceDaily Headlines - Category: Science Source Type: news
More News: Cancer | Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Clinical Trials | Leukemia | Lymphoma | Non-Hodgkin's Lymphoma | Science | Study